• bitcoinBitcoin(BTC)$84,161.00-0.50%
  • ethereumEthereum(ETH)$2,689.05-1.06%
  • tetherTether(USDT)$1.000.00%
  • binancecoinBNB(BNB)$775.00-0.55%
  • rippleXRP(XRP)$1.55-3.01%
  • usd-coinUSDC(USDC)$1.000.00%
  • solanaSolana(SOL)$121.290.37%
  • tronTRON(TRX)$0.336743-0.11%
  • zcashZcash(ZEC)$1,541.80-3.54%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.02-0.30%
  • HyperliquidHyperliquid(HYPE)$92.16-1.30%
  • dogecoinDogecoin(DOGE)$0.097632-0.41%
  • chainlinkChainlink(LINK)$14.261.27%
  • moneroMonero(XMR)$553.74-2.55%
  • whitebitWhiteBIT Coin(WBT)$83.98-0.64%
  • USDSUSDS(USDS)$1.000.00%
  • cardanoCardano(ADA)$0.2570900.71%
  • RainRain(RAIN)$0.0123793.85%
  • leo-tokenLEO Token(LEO)$8.961.52%
  • stellarStellar(XLM)$0.218792-1.93%
  • bitcoin-cashBitcoin Cash(BCH)$337.960.53%
  • nearNEAR Protocol(NEAR)$4.91-2.28%
  • uniswapUniswap(UNI)$9.62-1.28%
  • litecoinLitecoin(LTC)$73.133.93%
  • CantonCanton(CC)$0.1347448.77%
  • Ethena USDeEthena USDe(USDE)$1.00-0.02%
  • avalanche-2Avalanche(AVAX)$10.953.44%
  • suiSui(SUI)$1.183.39%
  • daiDai(DAI)$1.000.01%
  • USD1USD1(USD1)$1.000.01%
  • hedera-hashgraphHedera(HBAR)$0.094078-1.77%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.462.51%
  • BittensorBittensor(TAO)$329.807.98%
  • shiba-inuShiba Inu(SHIB)$0.000006-0.10%
  • crypto-com-chainCronos(CRO)$0.065386-0.47%
  • Global DollarGlobal Dollar(USDG)$1.000.01%
  • EthenaEthena(ENA)$0.28014116.49%
  • paypal-usdPayPal USD(PYUSD)$1.000.00%
  • MemeCoreMemeCore(M)$1.232.54%
  • OndoOndo(ONDO)$0.562.88%
  • tether-goldTether Gold(XAUT)$4,280.50-0.42%
  • BitwayBitway(BTW)$0.95-17.04%
  • okbOKB(OKB)$121.470.48%
  • Ripple USDRipple USD(RLUSD)$1.00-0.01%
  • Circle USYCCircle USYC(USYC)$1.140.03%
  • aaveAave(AAVE)$154.324.13%
  • mantleMantle(MNT)$0.714.08%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.01%
  • Pump.funPump.fun(PUMP)$0.0045037.47%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

EvolutionaryScale Releases ESM Cambrian: A New Family of Protein Language Models which Focuses on Creating Representations of the Underlying Biology of Protein

December 4, 2024
in AI & Technology
Reading Time: 7 mins read
A A
EvolutionaryScale Releases ESM Cambrian: A New Family of Protein Language Models which Focuses on Creating Representations of the Underlying Biology of Protein
ShareShareShareShareShare

Understanding protein sequences and their functions has always been a challenging aspect of protein research. Proteins, often described as the building blocks of life, are made up of long, complex sequences that determine their roles in biological systems. Despite advancements in computational biology, making sense of these sequences in a meaningful way is still a difficult task. Traditional methods for analyzing proteins are both time-consuming and expensive. Even with recent technological progress, researchers struggle to map the vast diversity of protein structures and their functional variations found in nature. This gap between available data and practical insights remains a significant hurdle in developing new therapeutics, bioengineering solutions, and tackling broader challenges in health and environmental sciences. The need for a comprehensive tool to analyze proteins at an unprecedented scale has never been more urgent.

EvolutionaryScale has released ESM Cambrian, a new language model trained on protein sequences at a scale that captures the diversity of life on Earth. ESM Cambrian represents a major step forward in bioinformatics, using machine learning techniques to better understand protein structures and functions. The model has been trained on millions of protein sequences, covering an immense range of biodiversity, to uncover the underlying patterns and relationships in proteins. Just as large language models have transformed our understanding of human language, ESM Cambrian focuses on protein sequences that are fundamental to biological processes. It aims to be a versatile model capable of predicting structure, function, and facilitating new discoveries across different species and protein families.

YOU MAY ALSO LIKE

Exa Launches Agent Ultra: A Subagent Swarm Deep Research API Built for Exhaustive List Building

End-to-End Multimodal Data Augmentation and Adversarial Robustness Benchmark with AugLy for Images, Text, Audio, and PyTorch

Technical Details

The technical foundation of ESM Cambrian is as impressive as its goals. EvolutionaryScale has released different versions of the model, including ESM C 300M and ESM C 600M, with the weights openly available for the research community. These models strike a balance between scale and practicality, enabling scientists to make powerful predictions without the infrastructure challenges that come with very large models. The largest variant, ESM C 6B, is available on EvolutionaryScale Forge for academic research and on AWS Sagemaker for commercial use, with plans to launch on NVIDIA BioNemo soon. These platforms make it easy for users in both academic and industrial settings to access this tool.

The model, based on the transformer architecture, uses self-attention mechanisms to identify complex relationships within protein sequences, making it well-suited for tasks like predicting protein folding or discovering novel functions. One of the main benefits of ESM Cambrian is its ability to generalize knowledge across different proteins, potentially speeding up the discovery of new drugs and synthetic biology applications.

ESM Cambrian was trained in two stages to achieve its high performance. In Stage 1, for the first 1 million training steps, the model used a context length of 512, with metagenomic data making up 64% of the training dataset. In Stage 2, the model underwent an additional 500,000 training steps, during which the context length was increased to 2048, and the proportion of metagenomic data was reduced to 37.5%. This staged approach allowed the model to learn effectively from a diverse set of protein sequences, improving its ability to generalize across different proteins.

Early Results and Insights

Early testing of ESM Cambrian has shown promising results. The model’s ability to predict the structure and function of protein sequences is comparable to traditional experimental methods, offering significant savings in both time and cost. Evaluations were conducted using the methodology of Rao et al. to measure the unsupervised learning of protein tertiary structure through contact maps. A logistic regression was used to identify contacts, and the precision of the top L contacts (P@L) was evaluated for proteins of length L, with a sequence separation of 6 or more residues. The average P@L was computed on a temporally held-out set of protein structures (with a cutoff date of May 1, 2023) for scaling laws and on the CASP15 benchmark for performance evaluation. Initial insights suggest that ESM Cambrian performs well in generalizing across poorly studied protein families, helping researchers uncover hidden relationships in sequences that are otherwise difficult to analyze. Its predictive accuracy also opens new possibilities in enzyme engineering, where understanding the subtle nuances of protein activity is crucial.

The availability of ESM Cambrian on platforms like AWS Sagemaker and NVIDIA BioNemo will make it easier for commercial users to integrate machine learning tools into their existing workflows. EvolutionaryScale’s decision to release open weights for ESM C 300M and ESM C 600M reflects a commitment to open science, encouraging collaboration to better understand the fundamentals of life on Earth.

Conclusion

The release of ESM Cambrian by EvolutionaryScale marks an important milestone in computational biology and protein science. By providing a model that can analyze protein sequences at a scale that captures the diversity of Earth’s biodiversity, EvolutionaryScale has shown the potential of applying AI in biological research and opened up numerous opportunities for accelerating discovery and innovation. ESM Cambrian is set to play a key role in protein engineering, drug discovery, and gaining a deeper understanding of biological systems. As the scientific community begins to explore the applications of this model, it is clear that the future of protein research is evolving, with tools like ESM Cambrian leading the way.


Check out the Details and GitHub Page. All credit for this research goes to the researchers of this project. Also, don’t forget to follow us on Twitter and join our Telegram Channel and LinkedIn Group. If you like our work, you will love our newsletter.. Don’t Forget to join our 60k+ ML SubReddit.

🚨 [Must Attend Webinar]: ‘Transform proofs-of-concept into production-ready AI applications and agents’ (Promoted)


Asif Razzaq is the CEO of Marktechpost Media Inc.. As a visionary entrepreneur and engineer, Asif is committed to harnessing the potential of Artificial Intelligence for social good. His most recent endeavor is the launch of an Artificial Intelligence Media Platform, Marktechpost, which stands out for its in-depth coverage of machine learning and deep learning news that is both technically sound and easily understandable by a wide audience. The platform boasts of over 2 million monthly views, illustrating its popularity among audiences.

🚨🚨FREE AI WEBINAR: ‘Fast-Track Your LLM Apps with deepset & Haystack'(Promoted)


Credit: Source link

ShareTweetSendSharePin

Related Posts

Exa Launches Agent Ultra: A Subagent Swarm Deep Research API Built for Exhaustive List Building
AI & Technology

Exa Launches Agent Ultra: A Subagent Swarm Deep Research API Built for Exhaustive List Building

September 26, 2026
End-to-End Multimodal Data Augmentation and Adversarial Robustness Benchmark with AugLy for Images, Text, Audio, and PyTorch
AI & Technology

End-to-End Multimodal Data Augmentation and Adversarial Robustness Benchmark with AugLy for Images, Text, Audio, and PyTorch

September 26, 2026
Liquid AI Releases LFM2.5-VL-3B-DSpark: Speculative Decoding for Vision-Language Models With Up to 3.13x Faster Decoding
AI & Technology

Liquid AI Releases LFM2.5-VL-3B-DSpark: Speculative Decoding for Vision-Language Models With Up to 3.13x Faster Decoding

September 25, 2026
How To Stop Meta Training Its AI Models On Your Smart Glasses’ Visual Data
AI & Technology

How To Stop Meta Training Its AI Models On Your Smart Glasses’ Visual Data

September 25, 2026
Next Post
MP Materials: Mission Critical And Ready To Double

MP Materials: Mission Critical And Ready To Double

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Quadient S.A. 2027 Q2 – Results – Earnings Call Presentation (OTCMKTS:NPACY) 2026-09-24

Quadient S.A. 2027 Q2 – Results – Earnings Call Presentation (OTCMKTS:NPACY) 2026-09-24

September 24, 2026
Lindsay Clancy Trial: An inside look at the evidence at the center of the case as jurors deliberate

Lindsay Clancy Trial: An inside look at the evidence at the center of the case as jurors deliberate

September 22, 2026
EverCommerce: AI Has A Route To Customers, But Growth Still Needs Repair

EverCommerce: AI Has A Route To Customers, But Growth Still Needs Repair

September 26, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!